Caudal Type Homeobox 2 (CDX2) Peptide
CDX2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CDX2 products
- CDX2 (Caudal Type Homeobox 2 (CDX2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CDX2 antibody (Catalog #: ARP31476_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
Caudal Type Homeobox 2 (CDX2) peptide
CDX2 Reactivity: Human, Mouse, Rat, Dog Host: Synthetic BP, Imm
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CDX2 (Caudal Type Homeobox 2 (CDX2))
- Synonyms
- CDX2 Peptide, MGC130987 Peptide, cdx3-like Peptide, CDX-3 Peptide, CDX3 Peptide, CDX-2 Peptide, Cdx-2 Peptide, caudal type homeobox 2 Peptide, caudal type homeobox 2 L homeolog Peptide, caudal type homeo box 2 Peptide, CDX2 Peptide, cdx2.L Peptide, Cdx2 Peptide
- Background
-
CDX2 encodes a protein that plays an important role in gallbladder carcinogenesis with intestinal differentiation. Cdx2 is a highly sensitive marker for Barrett's esophagus.
Alias Symbols: CDX3, CDX-3
Protein Interaction Partner: ACAT2,CDK2,CDX2,CREBBP,EP300,GSK3B,HNF1A,MAPK1,MAPK14,PAX6,UBB,EP300,HNF1A,PAX6
Protein Size: 313 - Molecular Weight
- 34 kDa
- Gene ID
- 1045
- NCBI Accession
- NM_001265, NP_001256
- UniProt
- Q99626
-
You are here:
